Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence ; volume:15 ; number:1 ; day:11 ; month:6 ; year:2022 ; pages:1-30 ; date:12.2022
Journal of hematology & oncology ; 15, Heft 1 (11.6.2022), 1-30, 12.2022
- Creator
-
Kreatsoulas, Daniel
Bolyard, Chelsea
Wu, Bill X.
Cam, Hakan
Giglio, Pierre
Li, Zihai
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-022-01298-0
- URN
-
urn:nbn:de:101:1-2022080707313805778439
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kreatsoulas, Daniel
- Bolyard, Chelsea
- Wu, Bill X.
- Cam, Hakan
- Giglio, Pierre
- Li, Zihai
- SpringerLink (Online service)
Other Objects (12)
Current Advances in Immunotherapy for Glioblastoma
Natural killer cell immunotherapy in glioblastoma
Clinical and Translational Advances in Glioma Immunotherapy
Peptide immunotherapy for childhood allergy - addressing translational challenges
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: the promise of combination strategies
Immunocompetent murine models for the study of glioblastoma immunotherapy
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment
Current Advances in Immunotherapy for Glioblastoma
Natural killer cell immunotherapy in glioblastoma
Clinical and Translational Advances in Glioma Immunotherapy
Peptide immunotherapy for childhood allergy - addressing translational challenges
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: the promise of combination strategies
Immunocompetent murine models for the study of glioblastoma immunotherapy
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment
Current Advances in Immunotherapy for Glioblastoma
Natural killer cell immunotherapy in glioblastoma
Clinical and Translational Advances in Glioma Immunotherapy
Peptide immunotherapy for childhood allergy - addressing translational challenges
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: the promise of combination strategies
Immunocompetent murine models for the study of glioblastoma immunotherapy
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
MRP3: a molecular target for human glioblastoma multiforme immunotherapy